img

Global Plasmid DNA CDMO Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Plasmid DNA CDMO Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Plasmid DNA CDMO Market
Global Plasmid DNA CDMO market is expected to reach to US$ 201 million in 2024, with a positive growth of %, compared with US$ 168.9 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Plasmid DNA CDMO industry is evaluated to reach US$ 664 million in 2029. The CAGR will be 22.0% during 2024 to 2029.
Globally, Plasmid DNA CDMO key companies include GenScript ProBio, Biovian, Biomay, VGXI, Esco Aster, Catalent, Richter-Helm BioLogics, Cytovance Biologics and Cobra Biologics, etc. GenScript ProBio, Biovian, Biomay are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Plasmid DNA CDMO were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the share will be % in 2029. Moreover, China, plays a key role in the whole Plasmid DNA CDMO market and estimated to attract more attentions from industry insiders and investors.
Plasmid DNA CDMO can be divided into GMP Grade Plasmid DNA and Non-GMP Grade Plasmid DNA, etc. GMP Grade Plasmid DNA is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2029.
Plasmid DNA CDMO is widely used in various fields, such as DNA Vaccines, Gene Therapy, Immunotherapy and Others, etc. DNA Vaccines provides greatest supports to the Plasmid DNA CDMO industry development. In 2022, global % revenue of Plasmid DNA CDMO went into DNA Vaccines filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Plasmid DNA CDMO market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Plasmid DNA CDMO market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


GenScript ProBio
Biovian
Biomay
VGXI
Esco Aster
Catalent
Richter-Helm BioLogics
Cytovance Biologics
Cobra Biologics
Obiosh
Thermo Fisher
Aldevron(Danaher)
Charles River Laboratories
WuXi AppTec
AGC Biologics
AcuraBio
GENE Chem
Eurogentec
PlasmidFactory
Segment by Type
GMP Grade Plasmid DNA
Non-GMP Grade Plasmid DNA

Segment by Application


DNA Vaccines
Gene Therapy
Immunotherapy
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Plasmid DNA CDMO introduction, etc. Plasmid DNA CDMO Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Plasmid DNA CDMO
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasmid DNA CDMO Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 GMP Grade Plasmid DNA
1.2.3 Non-GMP Grade Plasmid DNA
1.3 Market by Application
1.3.1 Global Plasmid DNA CDMO Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 DNA Vaccines
1.3.3 Gene Therapy
1.3.4 Immunotherapy
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Plasmid DNA CDMO Market Perspective (2018-2029)
2.2 Global Plasmid DNA CDMO Growth Trends by Region
2.2.1 Plasmid DNA CDMO Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Plasmid DNA CDMO Historic Market Size by Region (2018-2024)
2.2.3 Plasmid DNA CDMO Forecasted Market Size by Region (2024-2029)
2.3 Plasmid DNA CDMO Market Dynamics
2.3.1 Plasmid DNA CDMO Industry Trends
2.3.2 Plasmid DNA CDMO Market Drivers
2.3.3 Plasmid DNA CDMO Market Challenges
2.3.4 Plasmid DNA CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Plasmid DNA CDMO by Players
3.1.1 Global Plasmid DNA CDMO Revenue by Players (2018-2024)
3.1.2 Global Plasmid DNA CDMO Revenue Market Share by Players (2018-2024)
3.2 Global Plasmid DNA CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Plasmid DNA CDMO, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Plasmid DNA CDMO Market Concentration Ratio
3.4.1 Global Plasmid DNA CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasmid DNA CDMO Revenue in 2022
3.5 Global Key Players of Plasmid DNA CDMO Head office and Area Served
3.6 Global Key Players of Plasmid DNA CDMO, Product and Application
3.7 Global Key Players of Plasmid DNA CDMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Plasmid DNA CDMO Breakdown Data by Type
4.1 Global Plasmid DNA CDMO Historic Market Size by Type (2018-2024)
4.2 Global Plasmid DNA CDMO Forecasted Market Size by Type (2024-2029)
5 Plasmid DNA CDMO Breakdown Data by Application
5.1 Global Plasmid DNA CDMO Historic Market Size by Application (2018-2024)
5.2 Global Plasmid DNA CDMO Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Plasmid DNA CDMO Market Size (2018-2029)
6.2 North America Plasmid DNA CDMO Market Size by Type
6.2.1 North America Plasmid DNA CDMO Market Size by Type (2018-2024)
6.2.2 North America Plasmid DNA CDMO Market Size by Type (2024-2029)
6.2.3 North America Plasmid DNA CDMO Market Share by Type (2018-2029)
6.3 North America Plasmid DNA CDMO Market Size by Application
6.3.1 North America Plasmid DNA CDMO Market Size by Application (2018-2024)
6.3.2 North America Plasmid DNA CDMO Market Size by Application (2024-2029)
6.3.3 North America Plasmid DNA CDMO Market Share by Application (2018-2029)
6.4 North America Plasmid DNA CDMO Market Size by Country
6.4.1 North America Plasmid DNA CDMO Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Plasmid DNA CDMO Market Size by Country (2018-2024)
6.4.3 North America Plasmid DNA CDMO Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Plasmid DNA CDMO Market Size (2018-2029)
7.2 Europe Plasmid DNA CDMO Market Size by Type
7.2.1 Europe Plasmid DNA CDMO Market Size by Type (2018-2024)
7.2.2 Europe Plasmid DNA CDMO Market Size by Type (2024-2029)
7.2.3 Europe Plasmid DNA CDMO Market Share by Type (2018-2029)
7.3 Europe Plasmid DNA CDMO Market Size by Application
7.3.1 Europe Plasmid DNA CDMO Market Size by Application (2018-2024)
7.3.2 Europe Plasmid DNA CDMO Market Size by Application (2024-2029)
7.3.3 Europe Plasmid DNA CDMO Market Share by Application (2018-2029)
7.4 Europe Plasmid DNA CDMO Market Size by Country
7.4.1 Europe Plasmid DNA CDMO Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Plasmid DNA CDMO Market Size by Country (2018-2024)
7.4.3 Europe Plasmid DNA CDMO Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Plasmid DNA CDMO Market Size (2018-2029)
8.2 China Plasmid DNA CDMO Market Size by Type
8.2.1 China Plasmid DNA CDMO Market Size by Type (2018-2024)
8.2.2 China Plasmid DNA CDMO Market Size by Type (2024-2029)
8.2.3 China Plasmid DNA CDMO Market Share by Type (2018-2029)
8.3 China Plasmid DNA CDMO Market Size by Application
8.3.1 China Plasmid DNA CDMO Market Size by Application (2018-2024)
8.3.2 China Plasmid DNA CDMO Market Size by Application (2024-2029)
8.3.3 China Plasmid DNA CDMO Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Plasmid DNA CDMO Market Size (2018-2029)
9.2 Asia Plasmid DNA CDMO Market Size by Type
9.2.1 Asia Plasmid DNA CDMO Market Size by Type (2018-2024)
9.2.2 Asia Plasmid DNA CDMO Market Size by Type (2024-2029)
9.2.3 Asia Plasmid DNA CDMO Market Share by Type (2018-2029)
9.3 Asia Plasmid DNA CDMO Market Size by Application
9.3.1 Asia Plasmid DNA CDMO Market Size by Application (2018-2024)
9.3.2 Asia Plasmid DNA CDMO Market Size by Application (2024-2029)
9.3.3 Asia Plasmid DNA CDMO Market Share by Application (2018-2029)
9.4 Asia Plasmid DNA CDMO Market Size by Region
9.4.1 Asia Plasmid DNA CDMO Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Plasmid DNA CDMO Market Size by Region (2018-2024)
9.4.3 Asia Plasmid DNA CDMO Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Plasmid DNA CDMO Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Plasmid DNA CDMO Market Size by Type
10.2.1 Middle East, Africa, and Latin America Plasmid DNA CDMO Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Plasmid DNA CDMO Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Plasmid DNA CDMO Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Plasmid DNA CDMO Market Size by Application
10.3.1 Middle East, Africa, and Latin America Plasmid DNA CDMO Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Plasmid DNA CDMO Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Plasmid DNA CDMO Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Plasmid DNA CDMO Market Size by Country
10.4.1 Middle East, Africa, and Latin America Plasmid DNA CDMO Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Plasmid DNA CDMO Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Plasmid DNA CDMO Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 GenScript ProBio
11.1.1 GenScript ProBio Company Details
11.1.2 GenScript ProBio Business Overview
11.1.3 GenScript ProBio Plasmid DNA CDMO Introduction
11.1.4 GenScript ProBio Revenue in Plasmid DNA CDMO Business (2018-2024)
11.1.5 GenScript ProBio Recent Developments
11.2 Biovian
11.2.1 Biovian Company Details
11.2.2 Biovian Business Overview
11.2.3 Biovian Plasmid DNA CDMO Introduction
11.2.4 Biovian Revenue in Plasmid DNA CDMO Business (2018-2024)
11.2.5 Biovian Recent Developments
11.3 Biomay
11.3.1 Biomay Company Details
11.3.2 Biomay Business Overview
11.3.3 Biomay Plasmid DNA CDMO Introduction
11.3.4 Biomay Revenue in Plasmid DNA CDMO Business (2018-2024)
11.3.5 Biomay Recent Developments
11.4 VGXI
11.4.1 VGXI Company Details
11.4.2 VGXI Business Overview
11.4.3 VGXI Plasmid DNA CDMO Introduction
11.4.4 VGXI Revenue in Plasmid DNA CDMO Business (2018-2024)
11.4.5 VGXI Recent Developments
11.5 Esco Aster
11.5.1 Esco Aster Company Details
11.5.2 Esco Aster Business Overview
11.5.3 Esco Aster Plasmid DNA CDMO Introduction
11.5.4 Esco Aster Revenue in Plasmid DNA CDMO Business (2018-2024)
11.5.5 Esco Aster Recent Developments
11.6 Catalent
11.6.1 Catalent Company Details
11.6.2 Catalent Business Overview
11.6.3 Catalent Plasmid DNA CDMO Introduction
11.6.4 Catalent Revenue in Plasmid DNA CDMO Business (2018-2024)
11.6.5 Catalent Recent Developments
11.7 Richter-Helm BioLogics
11.7.1 Richter-Helm BioLogics Company Details
11.7.2 Richter-Helm BioLogics Business Overview
11.7.3 Richter-Helm BioLogics Plasmid DNA CDMO Introduction
11.7.4 Richter-Helm BioLogics Revenue in Plasmid DNA CDMO Business (2018-2024)
11.7.5 Richter-Helm BioLogics Recent Developments
11.8 Cytovance Biologics
11.8.1 Cytovance Biologics Company Details
11.8.2 Cytovance Biologics Business Overview
11.8.3 Cytovance Biologics Plasmid DNA CDMO Introduction
11.8.4 Cytovance Biologics Revenue in Plasmid DNA CDMO Business (2018-2024)
11.8.5 Cytovance Biologics Recent Developments
11.9 Cobra Biologics
11.9.1 Cobra Biologics Company Details
11.9.2 Cobra Biologics Business Overview
11.9.3 Cobra Biologics Plasmid DNA CDMO Introduction
11.9.4 Cobra Biologics Revenue in Plasmid DNA CDMO Business (2018-2024)
11.9.5 Cobra Biologics Recent Developments
11.10 Obiosh
11.10.1 Obiosh Company Details
11.10.2 Obiosh Business Overview
11.10.3 Obiosh Plasmid DNA CDMO Introduction
11.10.4 Obiosh Revenue in Plasmid DNA CDMO Business (2018-2024)
11.10.5 Obiosh Recent Developments
11.11 Thermo Fisher
11.11.1 Thermo Fisher Company Details
11.11.2 Thermo Fisher Business Overview
11.11.3 Thermo Fisher Plasmid DNA CDMO Introduction
11.11.4 Thermo Fisher Revenue in Plasmid DNA CDMO Business (2018-2024)
11.11.5 Thermo Fisher Recent Developments
11.12 Aldevron(Danaher)
11.12.1 Aldevron(Danaher) Company Details
11.12.2 Aldevron(Danaher) Business Overview
11.12.3 Aldevron(Danaher) Plasmid DNA CDMO Introduction
11.12.4 Aldevron(Danaher) Revenue in Plasmid DNA CDMO Business (2018-2024)
11.12.5 Aldevron(Danaher) Recent Developments
11.13 Charles River Laboratories
11.13.1 Charles River Laboratories Company Details
11.13.2 Charles River Laboratories Business Overview
11.13.3 Charles River Laboratories Plasmid DNA CDMO Introduction
11.13.4 Charles River Laboratories Revenue in Plasmid DNA CDMO Business (2018-2024)
11.13.5 Charles River Laboratories Recent Developments
11.14 WuXi AppTec
11.14.1 WuXi AppTec Company Details
11.14.2 WuXi AppTec Business Overview
11.14.3 WuXi AppTec Plasmid DNA CDMO Introduction
11.14.4 WuXi AppTec Revenue in Plasmid DNA CDMO Business (2018-2024)
11.14.5 WuXi AppTec Recent Developments
11.15 AGC Biologics
11.15.1 AGC Biologics Company Details
11.15.2 AGC Biologics Business Overview
11.15.3 AGC Biologics Plasmid DNA CDMO Introduction
11.15.4 AGC Biologics Revenue in Plasmid DNA CDMO Business (2018-2024)
11.15.5 AGC Biologics Recent Developments
11.16 AcuraBio
11.16.1 AcuraBio Company Details
11.16.2 AcuraBio Business Overview
11.16.3 AcuraBio Plasmid DNA CDMO Introduction
11.16.4 AcuraBio Revenue in Plasmid DNA CDMO Business (2018-2024)
11.16.5 AcuraBio Recent Developments
11.17 GENE Chem
11.17.1 GENE Chem Company Details
11.17.2 GENE Chem Business Overview
11.17.3 GENE Chem Plasmid DNA CDMO Introduction
11.17.4 GENE Chem Revenue in Plasmid DNA CDMO Business (2018-2024)
11.17.5 GENE Chem Recent Developments
11.18 Eurogentec
11.18.1 Eurogentec Company Details
11.18.2 Eurogentec Business Overview
11.18.3 Eurogentec Plasmid DNA CDMO Introduction
11.18.4 Eurogentec Revenue in Plasmid DNA CDMO Business (2018-2024)
11.18.5 Eurogentec Recent Developments
11.19 PlasmidFactory
11.19.1 PlasmidFactory Company Details
11.19.2 PlasmidFactory Business Overview
11.19.3 PlasmidFactory Plasmid DNA CDMO Introduction
11.19.4 PlasmidFactory Revenue in Plasmid DNA CDMO Business (2018-2024)
11.19.5 PlasmidFactory Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Plasmid DNA CDMO Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of GMP Grade Plasmid DNA
Table 3. Key Players of Non-GMP Grade Plasmid DNA
Table 4. Global Plasmid DNA CDMO Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Plasmid DNA CDMO Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Plasmid DNA CDMO Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Plasmid DNA CDMO Market Share by Region (2018-2024)
Table 8. Global Plasmid DNA CDMO Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Plasmid DNA CDMO Market Share by Region (2024-2029)
Table 10. Plasmid DNA CDMO Market Trends
Table 11. Plasmid DNA CDMO Market Drivers
Table 12. Plasmid DNA CDMO Market Challenges
Table 13. Plasmid DNA CDMO Market Restraints
Table 14. Global Plasmid DNA CDMO Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Plasmid DNA CDMO Revenue Share by Players (2018-2024)
Table 16. Global Top Plasmid DNA CDMO by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasmid DNA CDMO as of 2022)
Table 17. Global Plasmid DNA CDMO Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by Plasmid DNA CDMO Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of Plasmid DNA CDMO, Headquarters and Area Served
Table 20. Global Key Players of Plasmid DNA CDMO, Product and Application
Table 21. Global Key Players of Plasmid DNA CDMO, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Plasmid DNA CDMO Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Plasmid DNA CDMO Revenue Market Share by Type (2018-2024)
Table 25. Global Plasmid DNA CDMO Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Plasmid DNA CDMO Revenue Market Share by Type (2024-2029)
Table 27. Global Plasmid DNA CDMO Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Plasmid DNA CDMO Revenue Share by Application (2018-2024)
Table 29. Global Plasmid DNA CDMO Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Plasmid DNA CDMO Revenue Share by Application (2024-2029)
Table 31. North America Plasmid DNA CDMO Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America Plasmid DNA CDMO Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Plasmid DNA CDMO Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America Plasmid DNA CDMO Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Plasmid DNA CDMO Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Plasmid DNA CDMO Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America Plasmid DNA CDMO Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Plasmid DNA CDMO Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe Plasmid DNA CDMO Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Plasmid DNA CDMO Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe Plasmid DNA CDMO Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Plasmid DNA CDMO Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Plasmid DNA CDMO Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe Plasmid DNA CDMO Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Plasmid DNA CDMO Market Size by Type (2018-2024) & (US$ Million)
Table 46. China Plasmid DNA CDMO Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Plasmid DNA CDMO Market Size by Application (2018-2024) & (US$ Million)
Table 48. China Plasmid DNA CDMO Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Plasmid DNA CDMO Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia Plasmid DNA CDMO Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Plasmid DNA CDMO Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia Plasmid DNA CDMO Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Plasmid DNA CDMO Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Plasmid DNA CDMO Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia Plasmid DNA CDMO Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Plasmid DNA CDMO Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Plasmid DNA CDMO Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Plasmid DNA CDMO Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Plasmid DNA CDMO Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Plasmid DNA CDMO Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Plasmid DNA CDMO Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Plasmid DNA CDMO Market Size by Country (2024-2029) & (US$ Million)
Table 63. GenScript ProBio Company Details
Table 64. GenScript ProBio Business Overview
Table 65. GenScript ProBio Plasmid DNA CDMO Product
Table 66. GenScript ProBio Revenue in Plasmid DNA CDMO Business (2018-2024) & (US$ Million)
Table 67. GenScript ProBio Recent Developments
Table 68. Biovian Company Details
Table 69. Biovian Business Overview
Table 70. Biovian Plasmid DNA CDMO Product
Table 71. Biovian Revenue in Plasmid DNA CDMO Business (2018-2024) & (US$ Million)
Table 72. Biovian Recent Developments
Table 73. Biomay Company Details
Table 74. Biomay Business Overview
Table 75. Biomay Plasmid DNA CDMO Product
Table 76. Biomay Revenue in Plasmid DNA CDMO Business (2018-2024) & (US$ Million)
Table 77. Biomay Recent Developments
Table 78. VGXI Company Details
Table 79. VGXI Business Overview
Table 80. VGXI Plasmid DNA CDMO Product
Table 81. VGXI Revenue in Plasmid DNA CDMO Business (2018-2024) & (US$ Million)
Table 82. VGXI Recent Developments
Table 83. Esco Aster Company Details
Table 84. Esco Aster Business Overview
Table 85. Esco Aster Plasmid DNA CDMO Product
Table 86. Esco Aster Revenue in Plasmid DNA CDMO Business (2018-2024) & (US$ Million)
Table 87. Esco Aster Recent Developments
Table 88. Catalent Company Details
Table 89. Catalent Business Overview
Table 90. Catalent Plasmid DNA CDMO Product
Table 91. Catalent Revenue in Plasmid DNA CDMO Business (2018-2024) & (US$ Million)
Table 92. Catalent Recent Developments
Table 93. Richter-Helm BioLogics Company Details
Table 94. Richter-Helm BioLogics Business Overview
Table 95. Richter-Helm BioLogics Plasmid DNA CDMO Product
Table 96. Richter-Helm BioLogics Revenue in Plasmid DNA CDMO Business (2018-2024) & (US$ Million)
Table 97. Richter-Helm BioLogics Recent Developments
Table 98. Cytovance Biologics Company Details
Table 99. Cytovance Biologics Business Overview
Table 100. Cytovance Biologics Plasmid DNA CDMO Product
Table 101. Cytovance Biologics Revenue in Plasmid DNA CDMO Business (2018-2024) & (US$ Million)
Table 102. Cytovance Biologics Recent Developments
Table 103. Cobra Biologics Company Details
Table 104. Cobra Biologics Business Overview
Table 105. Cobra Biologics Plasmid DNA CDMO Product
Table 106. Cobra Biologics Revenue in Plasmid DNA CDMO Business (2018-2024) & (US$ Million)
Table 107. Cobra Biologics Recent Developments
Table 108. Obiosh Company Details
Table 109. Obiosh Business Overview
Table 110. Obiosh Plasmid DNA CDMO Product
Table 111. Obiosh Revenue in Plasmid DNA CDMO Business (2018-2024) & (US$ Million)
Table 112. Obiosh Recent Developments
Table 113. Thermo Fisher Company Details
Table 114. Thermo Fisher Business Overview
Table 115. Thermo Fisher Plasmid DNA CDMO Product
Table 116. Thermo Fisher Revenue in Plasmid DNA CDMO Business (2018-2024) & (US$ Million)
Table 117. Thermo Fisher Recent Developments
Table 118. Aldevron(Danaher) Company Details
Table 119. Aldevron(Danaher) Business Overview
Table 120. Aldevron(Danaher) Plasmid DNA CDMO Product
Table 121. Aldevron(Danaher) Revenue in Plasmid DNA CDMO Business (2018-2024) & (US$ Million)
Table 122. Aldevron(Danaher) Recent Developments
Table 123. Charles River Laboratories Company Details
Table 124. Charles River Laboratories Business Overview
Table 125. Charles River Laboratories Plasmid DNA CDMO Product
Table 126. Charles River Laboratories Revenue in Plasmid DNA CDMO Business (2018-2024) & (US$ Million)
Table 127. Charles River Laboratories Recent Developments
Table 128. WuXi AppTec Company Details
Table 129. WuXi AppTec Business Overview
Table 130. WuXi AppTec Plasmid DNA CDMO Product
Table 131. WuXi AppTec Revenue in Plasmid DNA CDMO Business (2018-2024) & (US$ Million)
Table 132. WuXi AppTec Recent Developments
Table 133. AGC Biologics Company Details
Table 134. AGC Biologics Business Overview
Table 135. AGC Biologics Plasmid DNA CDMO Product
Table 136. AGC Biologics Revenue in Plasmid DNA CDMO Business (2018-2024) & (US$ Million)
Table 137. AGC Biologics Recent Developments
Table 138. AcuraBio Company Details
Table 139. AcuraBio Business Overview
Table 140. AcuraBio Plasmid DNA CDMO Product
Table 141. AcuraBio Revenue in Plasmid DNA CDMO Business (2018-2024) & (US$ Million)
Table 142. AcuraBio Recent Developments
Table 143. GENE Chem Company Details
Table 144. GENE Chem Business Overview
Table 145. GENE Chem Plasmid DNA CDMO Product
Table 146. GENE Chem Revenue in Plasmid DNA CDMO Business (2018-2024) & (US$ Million)
Table 147. GENE Chem Recent Developments
Table 148. Eurogentec Company Details
Table 149. Eurogentec Business Overview
Table 150. Eurogentec Plasmid DNA CDMO Product
Table 151. Eurogentec Revenue in Plasmid DNA CDMO Business (2018-2024) & (US$ Million)
Table 152. Eurogentec Recent Developments
Table 153. PlasmidFactory Company Details
Table 154. PlasmidFactory Business Overview
Table 155. PlasmidFactory Plasmid DNA CDMO Product
Table 156. PlasmidFactory Revenue in Plasmid DNA CDMO Business (2018-2024) & (US$ Million)
Table 157. PlasmidFactory Recent Developments
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Plasmid DNA CDMO Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Plasmid DNA CDMO Market Share by Type: 2022 VS 2029
Figure 3. GMP Grade Plasmid DNA Features
Figure 4. Non-GMP Grade Plasmid DNA Features
Figure 5. Global Plasmid DNA CDMO Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Plasmid DNA CDMO Market Share by Application: 2022 VS 2029
Figure 7. DNA Vaccines Case Studies
Figure 8. Gene Therapy Case Studies
Figure 9. Immunotherapy Case Studies
Figure 10. Others Case Studies
Figure 11. Plasmid DNA CDMO Report Years Considered
Figure 12. Global Plasmid DNA CDMO Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Plasmid DNA CDMO Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Plasmid DNA CDMO Market Share by Region: 2022 VS 2029
Figure 15. Global Plasmid DNA CDMO Market Share by Players in 2022
Figure 16. Global Top Plasmid DNA CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasmid DNA CDMO as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Plasmid DNA CDMO Revenue in 2022
Figure 18. North America Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Plasmid DNA CDMO Market Share by Type (2018-2029)
Figure 20. North America Plasmid DNA CDMO Market Share by Application (2018-2029)
Figure 21. North America Plasmid DNA CDMO Market Share by Country (2018-2029)
Figure 22. United States Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Plasmid DNA CDMO Market Size YoY (2018-2029) & (US$ Million)
Figure 25. Europe Plasmid DNA CDMO Market Share by Type (2018-2029)
Figure 26. Europe Plasmid DNA CDMO Market Share by Application (2018-2029)
Figure 27. Europe Plasmid DNA CDMO Market Share by Country (2018-2029)
Figure 28. Germany Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. China Plasmid DNA CDMO Market Size YoY (2018-2029) & (US$ Million)
Figure 35. China Plasmid DNA CDMO Market Share by Type (2018-2029)
Figure 36. China Plasmid DNA CDMO Market Share by Application (2018-2029)
Figure 37. Asia Plasmid DNA CDMO Market Size YoY (2018-2029) & (US$ Million)
Figure 38. Asia Plasmid DNA CDMO Market Share by Type (2018-2029)
Figure 39. Asia Plasmid DNA CDMO Market Share by Application (2018-2029)
Figure 40. Asia Plasmid DNA CDMO Market Share by Region (2018-2029)
Figure 41. Japan Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. China Taiwan Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Plasmid DNA CDMO Market Size YoY (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Plasmid DNA CDMO Market Share by Type (2018-2029)
Figure 49. Middle East, Africa, and Latin America Plasmid DNA CDMO Market Share by Application (2018-2029)
Figure 50. Middle East, Africa, and Latin America Plasmid DNA CDMO Market Share by Country (2018-2029)
Figure 51. Brazil Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mexico Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Turkey Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Israel Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GCC Countries Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. GenScript ProBio Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2024)
Figure 58. Biovian Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2024)
Figure 59. Biomay Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2024)
Figure 60. VGXI Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2024)
Figure 61. Esco Aster Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2024)
Figure 62. Catalent Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2024)
Figure 63. Richter-Helm BioLogics Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2024)
Figure 64. Cytovance Biologics Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2024)
Figure 65. Cobra Biologics Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2024)
Figure 66. Obiosh Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2024)
Figure 67. Thermo Fisher Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2024)
Figure 68. Aldevron(Danaher) Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2024)
Figure 69. Charles River Laboratories Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2024)
Figure 70. WuXi AppTec Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2024)
Figure 71. AGC Biologics Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2024)
Figure 72. AcuraBio Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2024)
Figure 73. GENE Chem Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2024)
Figure 74. Eurogentec Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2024)
Figure 75. PlasmidFactory Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2024)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed